| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |